Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

OP0108 Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

(2014) M. Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial

(2013) Feng Huang et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis

(2013) Marina Amaral de Ávila Machado et al.   RHEUMATOLOGY INTERNATIONAL

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial

(2012) In-Ho Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

(2012) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis

(2012) Zaiying Hu et al.   International Journal of Rheumatic Diseases

Predicting the outcome of ankylosing spondylitis therapy

(2011) N. Vastesaeger et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)

(2011) M. Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis

(2010) N. Barkham et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis

(2010) C. Escalas et al.   RHEUMATOLOGY

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort

(2009) Martin Rudwaleit et al.   ARTHRITIS AND RHEUMATISM

Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis

(2009) Nick Barkham et al.   ARTHRITIS AND RHEUMATISM

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

(2008) Hildrun Haibel et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

(2008) Robert D. Inman et al.   ARTHRITIS AND RHEUMATISM